Roopa Industries Limited (ROOPAIND.BO)
INR 76.5
(-0.57%)
INR 76.5
(-0.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 55.7 Million INR | 39.81% |
| 2022 | 45.41 Million INR | 17.6% |
| 2021 | 34.97 Million INR | 27.29% |
| 2020 | 26.18 Million INR | 6.3% |
| 2019 | 28.74 Million INR | 7.28% |
| 2018 | 25.41 Million INR | 51.78% |
| 2017 | 19 Million INR | -40.52% |
| 2016 | 23.05 Million INR | 61.66% |
| 2015 | 22.43 Million INR | 0.1% |
| 2014 | 14.85 Million INR | 291.94% |
| 2013 | -8.39 Million INR | -150.13% |
| 2012 | 16.47 Million INR | -30.41% |
| 2011 | 24.82 Million INR | 42.99% |
| 2010 | 14.85 Million INR | 6.41% |
| 2009 | 14.72 Million INR | 55.57% |
| 2008 | 10.29 Million INR | 22.03% |
| 2007 | 7.3 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 10.53 Million INR | -20.9% |
| 2023 Q2 | 17.18 Million INR | 65.48% |
| 2023 Q1 | 10.38 Million INR | 297.32% |
| 2023 Q3 | 8.91 Million INR | -48.16% |
| 2023 Q4 | 9.28 Million INR | 4.18% |
| 2023 FY | - INR | 12.04% |
| 2022 Q1 | 9.22 Million INR | -7.34% |
| 2022 Q2 | 15.75 Million INR | 70.75% |
| 2022 Q3 | 13.02 Million INR | -17.33% |
| 2022 Q4 | 2.61 Million INR | -79.92% |
| 2022 FY | - INR | 17.6% |
| 2021 FY | - INR | 27.29% |
| 2021 Q4 | 9.95 Million INR | 17.21% |
| 2021 Q3 | 8.49 Million INR | 7.57% |
| 2021 Q2 | 7.89 Million INR | 6.8% |
| 2021 Q1 | 7.39 Million INR | 18.46% |
| 2020 Q4 | 6.24 Million INR | -30.97% |
| 2020 Q2 | 4.56 Million INR | -27.92% |
| 2020 FY | - INR | 6.3% |
| 2020 Q1 | 6.33 Million INR | 29.11% |
| 2020 Q3 | 9.04 Million INR | 97.9% |
| 2019 FY | - INR | 7.28% |
| 2019 Q4 | 4.9 Million INR | -33.42% |
| 2019 Q2 | 5.64 Million INR | -25.74% |
| 2019 Q1 | 7.59 Million INR | 9.83% |
| 2019 Q3 | 7.37 Million INR | 30.66% |
| 2018 Q2 | 4.87 Million INR | -17.55% |
| 2018 FY | - INR | 51.78% |
| 2018 Q4 | 6.91 Million INR | 18.58% |
| 2018 Q3 | 5.83 Million INR | 19.62% |
| 2018 Q1 | 5.91 Million INR | -19.09% |
| 2017 FY | - INR | -40.52% |
| 2017 Q4 | 7.31 Million INR | 79.41% |
| 2017 Q3 | 4.07 Million INR | -8.92% |
| 2017 Q2 | 4.47 Million INR | 3.21% |
| 2017 Q1 | 4.33 Million INR | -41.36% |
| 2016 Q4 | 7.39 Million INR | 10.74% |
| 2016 FY | - INR | 61.66% |
| 2016 Q1 | 9.25 Million INR | 11.5% |
| 2016 Q2 | 4.74 Million INR | -48.7% |
| 2016 Q3 | 6.67 Million INR | 40.58% |
| 2015 FY | - INR | 0.1% |
| 2015 Q4 | 8.3 Million INR | 132.86% |
| 2015 Q3 | -25.26 Million INR | -673.19% |
| 2015 Q1 | 4.94 Million INR | 854.18% |
| 2015 Q2 | 4.4 Million INR | -10.79% |
| 2014 Q3 | 5.03 Million INR | 2.69% |
| 2014 Q4 | 517.82 Thousand INR | -89.72% |
| 2014 FY | - INR | 291.94% |
| 2014 Q2 | 4.9 Million INR | 11.65% |
| 2014 Q1 | 4.39 Million INR | 81.52% |
| 2013 Q2 | -1.48 Million INR | -548.49% |
| 2013 Q1 | 332 Thousand INR | -92.0% |
| 2013 Q4 | 2.42 Million INR | 155.4% |
| 2013 FY | - INR | -150.13% |
| 2013 Q3 | -4.36 Million INR | -193.35% |
| 2012 Q4 | 4.14 Million INR | 18.4% |
| 2012 FY | - INR | -30.41% |
| 2012 Q1 | 5.1 Million INR | -37.7% |
| 2012 Q2 | 3.8 Million INR | -25.46% |
| 2012 Q3 | 3.5 Million INR | -7.96% |
| 2011 FY | - INR | 42.99% |
| 2011 Q3 | 7.41 Million INR | 0.0% |
| 2011 Q4 | 8.19 Million INR | 10.53% |
| 2010 FY | - INR | 6.41% |
| 2009 FY | - INR | 55.57% |
| 2008 FY | - INR | 22.03% |
| 2008 Q4 | 2.29 Million INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 1.94 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -8620.259% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -380.844% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 37.422% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 33.867% |
| Sunil Healthcare Limited | 93.07 Million INR | 40.157% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -237.214% |
| MedPlus Health Services Limited | 3.94 Billion INR | 98.587% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 136.875% |
| Patidar Buildcon Limited | -5.52 Million INR | 1107.98% |
| Smruthi Organics Limited | 120.31 Million INR | 53.703% |
| Trident Lifeline Limited | 102.69 Million INR | 45.76% |
| PANJON LTD. | 4.08 Million INR | -1262.216% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 145.182% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -250.828% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 392.363% |
| Anuh Pharma Limited | 878.5 Million INR | 93.66% |
| Crestchem Limited | 30.33 Million INR | -83.624% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 614.892% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -104.836% |
| Tyche Industries Limited | 128.2 Million INR | 56.554% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 85.68% |
| Trimurthi Limited | -2.47 Million INR | 2347.358% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 74.283% |
| Norris Medicines Limited | -1.78 Million INR | 3222.0% |
| Zenlabs Ethica Limited | 27.09 Million INR | -105.569% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 85.604% |
| ANG Lifesciences India Limited | 90.66 Million INR | 38.562% |
| Parmax Pharma Limited | 22.93 Million INR | -142.838% |
| Veerhealth Care Limited | 15.99 Million INR | -248.24% |
| Deccan Health Care Limited | 37.5 Million INR | -48.512% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 78.085% |
| Makers Laboratories Limited | 25.81 Million INR | -115.795% |
| Lactose (India) Limited | 201.22 Million INR | 72.319% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 157.919% |
| Zenith Healthcare Limited | 4.98 Million INR | -1016.7% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 36.402% |
| Bacil Pharma Limited | -569.32 Thousand INR | 9883.777% |
| PRAVEG LIMITED | 321.43 Million INR | 82.671% |
| Denis Chem Lab Limited | 224.84 Million INR | 75.227% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 90.875% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 85.259% |
| Colinz Laboratories Limited | 5.42 Million INR | -926.179% |
| Godavari Drugs Limited | 134.62 Million INR | 58.625% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 13819.458% |
| Zenotech Laboratories Limited | 172.64 Million INR | 67.737% |
| Panchsheel Organics Limited | 189.36 Million INR | 70.586% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 87.588% |
| Vivanza Biosciences Limited | 11.2 Million INR | -397.153% |
| Phaarmasia Limited | -1.58 Million INR | 3620.923% |
| Sastasundar Ventures Limited | -203.51 Million INR | 127.37% |
| Medi-Caps Limited | 4.77 Million INR | -1067.491% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 2147.831% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 93.297% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 67.345% |
| Mercury Laboratories Limited | 101.18 Million INR | 44.953% |
| Gennex Laboratories Limited | 219.35 Million INR | 74.607% |
| BDH Industries Limited | 124.27 Million INR | 55.179% |
| Coral Laboratories Limited | 227.07 Million INR | 75.47% |
| Concord Drugs Limited | 40.52 Million INR | -37.465% |
| Bharat Parenterals Limited | 265.74 Million INR | 79.039% |
| Beryl Drugs Limited | 26.63 Million INR | -109.096% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 272.028% |
| Evoq Remedies Limited | 6.18 Million INR | -800.149% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 32.578% |
| Transchem Limited | 56.61 Million INR | 1.607% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -368.548% |
| Parnax Lab Limited | 243.59 Million INR | 77.134% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -24.321% |
| Kerala Ayurveda Limited | 70.78 Million INR | 21.312% |
| Cian Healthcare Limited | 122.56 Million INR | 54.555% |
| Trinity League India Limited | -26.25 Million INR | 312.17% |
| Syschem (India) Limited | 70.4 Million INR | 20.88% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 749.726% |
| Natural Capsules Limited | 219.9 Million INR | 74.67% |
| Auro Laboratories Limited | 121.73 Million INR | 54.244% |